I-131 Radioiodine Therapy – 50 mCi

Targeted nuclear medicine treatment, I-131 Radioiodine Therapy–50 mCi, is most often used in patients who have had a thyroidectomy for differentiated thyroid cancer (papillary thyroid cancer or follicular thyroid cancer). After thyroid surgery, some thyroid tissue may remain in the body, or microscopic cancer cells may be present. Radioiodine therapy uses radioactive iodine (I-131), which the thyroid naturally absorbs and uses to kill off these remaining cells.

At Molecular Diagnostics and Therapy, Dr. Nikunj Jain, Co-Founder and HOD – Nuclear Medicine, provides expert evaluation and personalised radioiodine treatment planning for patients undergoing I-131 Radioiodine Therapy after thyroid cancer surgery. 

This therapy takes advantage of the thyroid cells' natural tendency to take up iodine. It delivers iodine with precise targeting to the remaining thyroid cells, lowering the risk of recurrence and enabling more effective long-term monitoring with serum thyroglobulin markers and imaging.

Understanding I-131 and Its Therapeutic Role

Radioactive iodine (I-131) is a therapeutic isotope that I-131 emits beta radiation, which produces the therapeutic effect. It is more likely to damage parts of the thyroid gland but does not affect most of the surrounding tissues. After surgery for the thyroid, the following therapies are given with I-131:

• Destroy any remaining normal thyroid tissue.

• Eliminate microscopic cancer cells not removed during surgery.

• Improve the accuracy of future follow-up tests, such as thyroglobulin levels.

• Enable better interpretation of diagnostic scans.

• Reduce the risk of recurrence in differentiated thyroid cancer.

The use of 50 mCi of I-131 safely ablates iodine-avid cancer cells 

Why is the 50 mCi Dose Used?

A 50 mCi dose may be recommended in several clinical situations, including:

• Thyroid remnant ablation after total or near-total thyroidectomy.

• Low-risk or selected intermediate-risk thyroid cancer patients.

• Patients with minimal residual thyroid tissue.

• Cases where improved follow-up monitoring using thyroglobulin testing is required.

• Patients without evidence of distant metastasis.

Situations when a better follow-up of patients by performing thyroglobulin testing is warranted.

Preparation Before I-131 Radioiodine Therapy – 50 mCi

This amount may achieve effective tissue destruction with reasonable radiation dose exposure, versus higher therapeutic doses.

1. Elevation of TSH (Thyroid-Stimulating Hormone)

Appropriate preparation is essential for success. The two big achievements are when the TSH is elevated and when a low iodine diet is performed.

Thyroid Hormone Withdrawal

Reversible therapy is discontinued thyroid hormone use (such as levothyroxine) for 3–4 weeks before therapy. This makes TSH rise, because it causes temporary hypothyroidism. Some symptoms during this time may involve:

• Fatigue

• Weight gain

• Cold intolerance

• Constipation

• Low mood

• Slower heart rate

These symptoms usually resolve once thyroid hormone therapy is restarted.

Recombinant Human TSH (Thyrogen®)

You can also have the recombinant human TSH injections two days apart before therapy. Advantages include:

• Patients can continue taking thyroid hormone medication.

• Avoids symptoms of hypothyroidism.

• Suitable for elderly patients or those with other medical conditions.

Your doctor will determine the most appropriate preparation method.

2. Low-Iodine Diet

A low-iodine diet is typically recommended before therapy for 1-2 weeks. The diet reduces iodine availability/stores in the body and can improve uptake of administered radioiodine by iodine-avid tissue. 

Foods to Avoid

• Iodized salt and sea salt

• Dairy products (milk, cheese, yogurt, butter)

• Egg yolks

• Seafood and seaweed

• Soy products

• Foods containing red food dye

• Multivitamins containing iodine

Allowed Foods

• Fresh fruits and vegetables

• Plain rice and pasta

• Egg whites

• Non-iodized salt

• Fresh meat and poultry without additives

How is I-131 Radioiodine Therapy (50 mCi) Administered?

This therapy is typically given by mouth in the form of a capsule but can be given as a liquid. Important points include:

• Patients are usually asked to fast for about 4 hours before and after the dose.

• Most patients receiving 50 mCi can be treated on an outpatient basis, depending on institutional regulations.

• A brief observation period may follow administration.

After administration, the radioactive iodine enters the bloodstream and is taken up by the remaining thyroid tissue.

Radiation Safety Guidelines

Patients may receive instructions that they need to take precautions for the first 3–5 days after treatment, although the radiation levels can be relatively low.

• Avoid close contact with children and pregnant women.

• Sleep separately from others for a few days.

• Use separate towels and utensils if possible.

• Flush the toilet twice after use.

• Wash your hands frequently and maintain good hygiene.

• Drink plenty of fluids to help eliminate radioactive iodine from the body.

Your team of nuclear medicine practitioners will give you specific safety guidelines suitable for your case.

What Happens After the Therapy?

Whole-body scans may also be done after therapy with iodine to check that the iodine is being taken up, which usually occurs 3-7 days after treatment. This scan helps to:

• Confirm uptake in residual thyroid tissue.

• Identify any unexpected areas of iodine uptake.

• Assess the success of the ablation.

Long-term follow-up typically includes:

• Serum thyroglobulin testing (an important tumour marker).

• TSH and thyroid hormone level monitoring.

• Neck ultrasound or other imaging studies, if needed.

Benefits of I-131 Radioiodine Therapy – 50 mCi

• Minimally invasive treatment.

• Often performed as an outpatient procedure.

• Effective for thyroid remnant ablation after thyroid surgery.

• Helps improve the accuracy of long-term monitoring.

• Lower risk of side effects compared with higher therapeutic doses.

• Generally well tolerated by patients.

Possible Side Effects

Side effects with a 50 mCi dose are usually mild and temporary. Some patients may experience:

• Nausea

• Fatigue

• Mild neck discomfort or swelling

• Dry mouth or altered taste

• Temporary menstrual irregularities

These symptoms typically resolve within a short period.

Conclusion

When differentiated thyroid cancer is diagnosed, I-131 Radioiodine Therapy – 50 mCi may be an important treatment option for those patients after undergoing thyroidectomy. The treatment can ablate iodine-avid residual thyroid tissue and treat iodine-avid thyroid cancer cells. 

This therapy is a safe, effective, and targeted approach to the management of post-surgery thyroid cancer, with proper management steps, such as when TSH is elevated and following a low-iodine diet. Patients should always ask their endocrinologist or nuclear medicine specialist if they are suitable for this treatment in their individual case. At Molecular Diagnostics and Therapy, Dr. Nikunj Jain and the nuclear medicine team provide comprehensive treatment planning, personalised care, and long-term follow-up throughout the radioiodine therapy journey.